NeoGenomics falls on quarterly sales miss

NeoGenomics

18/02/2025 16:01

** Shares of cancer testing services company NeoGenomics
 NEO.O  fall ~15% to $12.2 in morning trade 
    ** NEO posts Q4 revenue of $172 million, missing analysts'
estimates of $173.2 million, according to data compiled by LSEG 
    ** Company reports adj. Q4 profit of 4 cents/shr, compared
to analysts' estimates of 3 cents/shr 
     ** Company forecasts net loss of $85 million to $76 million
for 2025  
     ** NEO also forecasts 2025 revenue in the range of $735
million to $745 million 
     ** Stock down 3.2% over the past 12 months 

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com;))